Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 646,999 | 546,050 | 488,998 | 453,001 | 387,367 |
| Marketable Securities | 25,582 | 19,224 | 17,955 | 14,185 | 23,109 |
| Receivables | 100,651 | 92,981 | 105,969 | 83,033 | 81,502 |
| Inventories | 6,882 | 6,100 | 6,384 | 7,198 | 6,915 |
| Other current assets | 35,378 | 8,636 | 6,916 | 8,121 | 7,455 |
| TOTAL | $838,800 | $691,354 | $642,692 | $579,252 | $522,405 |
| Non-Current Assets | |||||
| PPE Net | 1,440 | 1,376 | 1,378 | 1,257 | 750 |
| Investments And Advances | 105,831 | 107,008 | 103,245 | 108,874 | 94,222 |
| Intangibles | 95,380 | 101,341 | 107,302 | 113,263 | 119,225 |
| Other Non-Current Assets | 166,767 | 206,929 | 200,918 | 196,554 | 191,533 |
| TOTAL | $369,418 | $416,654 | $412,843 | $419,948 | $405,730 |
| Total Assets | $1,208,218 | $1,108,008 | $1,055,535 | $999,200 | $928,135 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,000 | 18,750 | 17,500 | 16,250 | 15,000 |
| Accounts payable and accrued liabilities | 26,341 | 28,301 | 17,459 | 13,744 | 10,532 |
| Accrued Expenses | 176,237 | 130,028 | 120,283 | 139,416 | 123,897 |
| Other current liabilities | 825 | 3,056 | 19,876 | 5,672 | 11,850 |
| TOTAL | $223,403 | $180,135 | $175,118 | $175,082 | $161,279 |
| Non-Current Liabilities | |||||
| Long Term Debt | 148,506 | 153,345 | 158,182 | 163,016 | 167,847 |
| Other Non-Current Liabilities | 1,186 | 1,448 | 1,710 | 1,947 | 2,205 |
| TOTAL | $149,692 | $154,793 | $159,892 | $164,963 | $170,052 |
| Total Liabilities | $373,095 | $334,928 | $335,010 | $340,045 | $331,331 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,596 | 57,533 | 57,424 | 57,346 | 57,031 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | 138,417 | 87,552 | 47,776 | 2,216 | -47,259 |
| Other shareholders' equity | 357 | 239 | 245 | 66 | 499 |
| TOTAL | $835,123 | $773,080 | $720,525 | $659,155 | $596,804 |
| Total Liabilities And Equity | $1,208,218 | $1,108,008 | $1,055,535 | $999,200 | $928,135 |